G. Fazekas et al., BRAIN MRI FINDINGS AND COGNITIVE IMPAIRMENT IN PATIENTS UNDERGOING CHRONIC-HEMODIALYSIS TREATMENT, Journal of the neurological sciences, 134(1-2), 1995, pp. 83-88
Although both morphologic cerebral damage and cognitive dysfunction ar
e known to occur in patients on chronic hemodialysis (CHD) their exten
t and possible relation have been rarely studied. We therefore perform
ed magnetic resonance imaging of the brain and neuropsychological test
ing in 30 consecutive CHD patients (mean age 58 years; range 37-69) an
d in an equal number of asymptomatic volunteers matched for age, sex a
nd major cerebrovascular risk factors. Twenty-four (80%) of the CHD pa
tients were demented according to the criteria of the Diagnostic and S
tatistical Manual of Mental Disorders IIIR and their mean scores on th
e Mini Mental State Examination (22.9 +/- 4 vs. 27.9 +/- 1.4; p < 0.00
1) and Mattis Dementia Rating Scale (112.3 +/- 21.5 vs. 141.9 +/- 2.3)
; p < 0.001) were significantly lower than those of controls. The brai
ns of CHD patients showed significantly more atrophy on visual rating
and semiquantitative morphometric measures. Multiple lacunes or conflu
ent white matter hyperintensities predominated in 10 (33%) patients, t
hree showed territorial infarcts and two a combination of both. Clinic
ally these findings were unexpected in almost half of individuals. Mar
ked cognitive impairment was associated with more extensive enlargemen
t of the third ventricle (5.8 +/- 1.8 vs. 7.3 +/- 2 mm; p < 0.04) and
the temporal hems (3.5 +/- 1.6 vs. 5.1 +/- 1.8 mm; p < 0.02) but not w
ith the presence of cerebral ischemic lesions or any difference in lab
oratory data. These results call attention to a very high rate of cere
bral damage in individuals undergoing CHD and suggest brain degenerati
on of probably toxic-metabolic etiology to be associated with severe c
ognitive impairment of these patients.